FilingIndex
← The Wire
GLUENasdaq

Monte Rosa Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · DE · CIK 1826457

Develops molecular glue degraders to selectively destroy disease-causing proteins using AI and proprietary tools

$1.54B
Market cap
$23.90
Last close
+7.2%
1D
+28.0%
5D
1.8M
Volume
Price · last 39 sessions+22.1%
May 4L $16.37 · H $23.90Jun 29
98
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end

Insider Activity

In the 90 days to Mar 4, 2026: 6 sold $1.2M.

DateInsiderActionSharesPriceValue
Mar 4, 2026Dunn EdmundPrincipal Accounting OfficerSell139$17.96$2K
Mar 2, 2026Warmuth MarkusPresident & CEOSell5,466$17.92$98K
Mar 2, 2026Dunn EdmundPrincipal Accounting OfficerSell536$17.50$9K
Feb 27, 2026Dunn EdmundPrincipal Accounting OfficerSell25,164$18.10$455K
Feb 23, 2026Janku FilipChief Medical OfficerSell9,189$19.50$179K
Jan 7, 2026Warmuth MarkusPresident & CEOSell3,707$23.24$86K
Jan 7, 2026Warmuth MarkusPresident & CEOSell1,450$23.88$35K
Jan 7, 2026Warmuth MarkusPresident & CEOSell309$24.57$8K
Jan 5, 2026Warmuth MarkusPresident & CEOSell10,135$15.17$154K
Jan 5, 2026Townson SharonChief Scientific OfficerSell3,155$15.17$48K
Jan 5, 2026Nickson PhilipChief Business & Legal OfficerSell3,155$15.17$48K
Jan 5, 2026Janku FilipChief Medical OfficerSell3,155$15.17$48K
Jan 5, 2026Champoux JenniferChief Operating OfficerSell2,629$15.17$40K
Jan 5, 2026Dunn EdmundPrincipal Accounting OfficerSell1,039$15.17$16K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance